Share
Seeger Weiss is pleased to announce that our firm, alongside partners Chris Seeger and Dave Buchanan, has been recognized for excellence in product liability in the newly released Chambers 2023 USA Guide. For more than three decades, Chambers has been an authoritative source of legal rankings and insights, with selection to tis guide regarded as one of the most prestigious awards for practicing attorneys.
For the third consecutive year, Seeger Weiss has been honored with the highest firm ranking, Band 1, in the Chambers USA Product Liability: Plaintiffs guide. Chambers stated that Seeger Weiss is “highly regarded for its representation of plaintiffs in mass tort litigation related to opioids, emissions and data security matters. It has significant experience in pharmaceutical and agricultural cases.” The guide added, “The firm is well known for expertise in settling complex multidistrict litigation mandates in both federal and state courts.”
Founding partner Chris Seeger was honored with Band 1 in Product Liability, marking the 17th consecutive year Chris was featured by Chambers in its annual guide. According to his Chambers profile, Chris is a “highly acclaimed practitioner who frequently acts on concussion class actions and automotive cases” and is “particularly esteemed for his work on opioid litigation.”
Chambers ranked partner Dave Buchanan Band 2 in Product Liability for the ninth straight year. Dave’s profile says he is a “renowned trial lawyer who has acted on high-profile cases including opioid litigation, pharmaceutical cases and consumer products.” Dave also rated in Band 3 for Chambers’ Global 2023 E-Discovery & Information Governance guide.
Chambers identifies the best practice groups and lawyers in 200 jurisdictions across the globe. The guide’s selection process is performed through in-depth market analysis and independent research conducted by a dedicated team of Research Analysts who speak to law firm clients/referees to analyze the level of client services and work each submitting law firm offers. The selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.